The emerging treatment of this peptide represents a exciting breakthrough in the management of type 2 diabetes. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide618575.yomoblog.com/49468630/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment